ribavirin has been researched along with Circoviridae Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, K; Guo, J; Khan, A; Li, H; Sun, N; Sun, P; Sun, Y; Wan, S; Xu, Y; Yin, W; Zheng, X | 1 |
| Chang, WY; Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Lee, LP; Lin, ZY; Wang, LY; Yu, ML | 2 |
2 trial(s) available for ribavirin and Circoviridae Infections
| Article | Year |
|---|---|
Matrine combined with Osthole inhibited the PERK apoptosis of splenic lymphocytes in PCV2-infected mice model.
Topics: Animals; Apoptosis; Circoviridae Infections; Circovirus; Endoplasmic Reticulum Chaperone BiP; Matrines; Mice; Ribavirin; Spleen | 2023 |
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Circoviridae Infections; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin | 2005 |
1 other study(ies) available for ribavirin and Circoviridae Infections
| Article | Year |
|---|---|
The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Base Sequence; Circoviridae; Circoviridae Infections; DNA, Viral; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Recombinant Proteins; Ribavirin; Taiwan; Viremia | 2004 |